Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
Keywords: مقاومت مکمل; Trastuzumab; Pertuzumab; Complement resistance; siRNA; Complement regulatory proteins; LipoplexCDC, complement-dependent cytotoxicity; CD46, membrane cofactor protein; CD55, decay accelerating factor; CD59, protectin; MAC, membrane attack complex; mCRP, m